市場調査レポート

商品コード

1736712

医薬品廃棄物管理市場規模：廃棄物タイプ、廃棄物の性質、エンドユーザー、地域別、2026～2032年

Pharmaceutical Waste Management Market Size By Waste Type, Nature of Waste, End-User & Region for 2026-2032

出版日: 2025年05月07日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日

価格

PDF (Single User License)

USD 3,950 571,802円

1名のみが、レポートにアクセスする事ができるライセンスです。レポートPDFのダウンロード、印刷は可能です。

PDF & Excel (5 User License)

USD 4,850 702,086円

5名までが、レポートにアクセスする事ができるライセンスです。レポートPDF・関連するExcelシートのダウンロード、印刷は可能です。

PDF & Excel (Enterprise User License)

USD 7,550 1,092,938円

人数制限なく、レポートにアクセスできるライセンスです。PDF形式のレポートと関連するExcel出力シートの両方をダウンロード、印刷する事が可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医薬品廃棄物管理市場の評価-2026～2032年

人口の増加やヘルスケア施設の充実により、世界的に医薬品廃棄物の発生量が増加していることが大きな問題となっています。人々は、不適切な医薬品廃棄物処理に関連する環境と健康リスクに対する認識を深めています。このような危険性を減らすと同時に、環境の持続可能性を確保するために、適切な医薬品廃棄物管理がますます重視されるようになっており、これによって市場は2024年に1兆6,623億5,000万米ドルの売上高を突破し、2032年には約2兆6,315億9,000万米ドルの評価額に達します。

さらに、医薬品廃棄物処理を管理する政府や環境団体によって施行された厳しい規則やガイドラインが、効果的な医薬品廃棄物管理ソリューションの需要を押し上げています。医薬品廃棄物の悪影響を減らすため、規制機関は安全で環境的に適切な廃棄を確保することにますます注力しています。さらに、医薬品廃棄物管理市場は、高温焼却、埋め立て、化学治療やオートクレーブなどの非焼却方法などの先進技術の採用増加によって牽引されています。これらの方法は、医薬品廃棄物の安全な処分と破壊を促進し、不適切な処分に関連する環境や健康への懸念を低減します。医薬品廃棄物管理のニーズの高まりにより、市場は2026～2032年にかけてCAGR 5.91%で成長します。

医薬品廃棄物管理市場定義/概要

医薬品廃棄物管理とは、医薬品のライフサイクル中に発生する様々なタイプの医薬品廃棄物を安全かつ効率的に処理することです。この廃棄物は、使用期限切れや未使用の医薬品、汚染された包装、医薬品の生産・流通・投与に使用されたその他の物品で構成されます。医薬品廃棄物管理の目的は、不適切な廃棄に関連する環境と健康への懸念、ならびに人体への潜在的な危害を軽減することです。

医薬品廃棄物管理は、医薬品製造工場、病院、クリニック、薬局、研究機関など様々な場面で利用されています。これらの組織では、使用期限切れや未使用の医薬品、汚染された包装、実験用化学品など、相当量の医薬品廃棄物が発生します。適切な廃棄物管理は、環境要件を満たし、汚染を減らし、公衆衛生を守るために不可欠です。

ヘルスケア廃棄物の増加は医薬品廃棄物管理市場をどのように牽引するか？

世界の医薬品事業は急速に拡大しており、その結果、廃棄物の排出量が増加しています。IQVIA Institute for Human Data Scienceによると、世界の医薬品支出は2026年までに1兆8,000億米ドルに達し、CAGR3～6%で増加すると予想されています。世界保健機関（WHO）によると、世界の医薬品生産量は1985年の3,000億単位から2020年には10倍の3兆単位以上に拡大します。この拡大は、効果的な処分を必要とする医薬品廃棄物の増加に直結します。

世界各国政府は、環境問題への関心の高まりを受けて、医薬品廃棄物処理に関するより厳しい法律を制定しています。環境保護庁（EPA）によると、米国では7,000を超える医療施設が毎年1万4,000トン以上の有害医薬品廃棄物を排出しています。欧州医薬品庁（EMA）によると、欧州連合（EU）では新薬申請の88%で環境リスク評価が必要とされており、これは2005年の10%から増加しています。

さらに、不適切な医薬品廃棄に関連する環境と健康の危険性に対する一般市民の意識の高まりが、市場の成長を後押ししています。Environmental Toxicology and Chemistry誌に掲載された研究によると、最も配合頻度の高い93種類の薬のうち88％が、地表水、地下水、飲料水に微量に含まれていることが判明しました。米国地質調査所によると、米国の河川の80％に微量の医薬品が含まれているといいます。このような意識は、米国麻薬取締局の「全国処方薬テイクバック・デー」のような、適切な廃棄のための追加プログラムを促しており、2021年10月だけで744,082ポンドの不要な処方薬が集まりました。

高額な設備投資は医薬品廃棄物管理市場の妨げになるか？

医薬品廃棄物管理を成功させるために必要な多額の資本支出は、病院、ヘルスケア機関、製薬企業にとって大きな障壁となっています。これらの組織は、環境要件に準拠し、汚染を削減する先進的廃棄物管理システムを構築するために多大な財源を割かなければなりません。有害と非有害の医薬品廃棄物を収集、処理、処分するための先進的技術を伴うこれらのシステムには高い費用がかかるため、これらの機関の予算には大きな負担となっています。

医薬品廃棄物管理に必要な高額な資本金は、小規模なヘルスケア施設や製薬会社の参入障壁となり、市場の拡大を阻害します。中小企業は、最新の廃棄物管理技術の導入に伴う多額の初期費用を捻出できず、代わりに安価で効果の低い選択肢や誤った廃棄技術を選んでしまう。これは環境汚染を拡大し、医薬品廃棄物管理の目標に反して公衆衛生を危険にさらすことになります。

世界の医薬品廃棄物管理市場概要
世界の医薬品廃棄物管理の絶対的収益機会
医薬品廃棄物管理の世界市場の魅力、地域別
医薬品廃棄物管理の世界市場地域別分析
医薬品廃棄物管理の世界市場：廃棄物の性質別
医薬品廃棄物管理の世界市場：廃棄物タイプ別
医薬品廃棄物管理の世界市場：エンドユーザー別
今後の市場機会
世界市場内訳

第4章市場展望

医薬品廃棄物管理の世界市場展望
市場促進要因
- 医薬品の適切な廃棄に関する政府の取り組みの増加
- 団塊世代の増加
抑制要因
- 医薬品の不適切な廃棄がもたらす影響についての認識不足
- 廃棄物処理に伴うコストの高さ
可能性
- 世界の研究開発活動の活発化。
COVID-19が世界の医薬品廃棄物管理市場に与える影響
マクロ経済分析
ポーターのファイブフォース分析
- 新規参入業者の脅威
- 代替品の脅威
- 供給企業の交渉力
- 買い手の交渉力
- 競争企業間の敵対関係の強さ
バリューチェーン分析

第5章廃棄物の性質別市場

概要
有害医薬品廃棄物
非有害医薬品廃棄物

第6章廃棄物タイプ別市場

概要
市販薬廃棄物
非管理処方薬
規制薬剤
危険ドラッグ

第7章エンドユーザー別市場

概要
病院
製薬会社
製薬・バイオテクノロジー企業
クリニック＆医院
その他

第8章地域別市場

概要
北米
- 北米市場スナップショット
- 米国
- カナダ
- メキシコ
欧州
- 欧州市場スナップショット
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
アジア太平洋
- アジア太平洋市場スナップショット
- 中国
- インド
- 日本
- その他のアジア太平洋
ラテンアメリカ
- ラテンアメリカ市場スナップショット
- ブラジル
- アルゼンチン
- その他のラテンアメリカ
中東・アフリカ
- 中東・アフリカ市場スナップショット
- アラブ首長国連邦
- サウジアラビア
- 南アフリカ
- その他の中東・アフリカ

第9章競合情勢

概要
各社の市場ランキング分析
地域別フットプリント
企業の産業別フットプリント

第10章企業プロファイル

STERICYCLE
DANIELS HEALTH
WASTE MANAGEMENT INC.
CARDINAL HEALTH, INC.
COVANTA HOLDING CORPORATION
US ECOLOGY, INC.
BIOMEDICAL WASTE SOLUTION LLC
BECTON, DICKINSON AND COMPANY
STRYKER
MEDICAL WASTE SERV内燃機関

図表

LIST OF TABLES

TABLE1 MOST FREQUENTLY USED PHARMACEUTICALS THAT ARE DETECTED IN WASTEWATERS.
TABLE 2 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
TABLE 3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE10 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE11 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE12 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE13 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE14 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE15 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE16 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE17 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE18 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE19 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 20 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 21 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 22 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 23 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 24 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 25 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 26 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 27 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 28 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 29 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 30 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 31 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 32 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 33 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 34 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 35 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 36 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 37 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 38 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 39 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 40 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 41 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 46 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 47 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 48 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 49 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 50 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 51 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 52 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 53 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 54 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 55 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
TABLE 56 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
TABLE 57 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 58 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 59 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)

LIST OF FIGURES

FIGURE1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET SEGMENTATION
FIGURE 2 RESEARCH TIMELINES
FIGURE 3 DATA TRIANGULATION
FIGURE 4 MARKET RESEARCH FLOW
FIGURE 5 DATA SOURCES
FIGURE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS, 2023-30
FIGURE 7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
FIGURE 8 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
FIGURE 9 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
FIGURE10 FUTURE MARKET OPPORTUNITIES
FIGURE11 NORTH AMERICA DOMINATED THE MARKET IN 2021
FIGURE12 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
FIGURE13 ANNUAL INCREASE IN THE RETIRED U.S. BABY BOOMER POPULATION (IN MILLIONS)
FIGURE14 ANNUAL R&D SPENDING BY PHRMA MEMBER FIRMS (IN BILLIONS OF 2019 DOLLARS)
FIGURE15 PORTER'S FIVE FORCES ANALYSIS
FIGURE16 VALUE CHAIN ANALYSIS
FIGURE17 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE
FIGURE18 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE
FIGURE19 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER
FIGURE 20 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
FIGURE 21 U.S. PHARMACEUTICAL R&D EXPENDITURE, 2000-2019 (USD MILLION)
FIGURE 22 U.S. MARKET SNAPSHOT
FIGURE 23 CANADA MARKET SNAPSHOT
FIGURE 24 MEXICO MARKET SNAPSHOT
FIGURE 25 PHARMACEUTICAL PRODUCTION IN EUROPE, 2019 (EUROS MILLION)
FIGURE 26 GERMANY MARKET SNAPSHOT
FIGURE 27 U.K. MARKET SNAPSHOT
FIGURE 28 FRANCE MARKET SNAPSHOT
FIGURE 29 ITALY MARKET SNAPSHOT
FIGURE 30 SPAIN MARKET SNAPSHOT
FIGURE 31 REST OF EUROPE MARKET SNAPSHOT
FIGURE 32 CHINA MARKET SNAPSHOT
FIGURE 33 INDIA MARKET SNAPSHOT
FIGURE 34 JAPAN MARKET SNAPSHOT
FIGURE 35 REST OF ASIA PACIFIC MARKET SNAPSHOT
FIGURE 36 BRAZIL MARKET SNAPSHOT
FIGURE 37 ARGENTINA MARKET SNAPSHOT
FIGURE 38 REST OF LATIN AMERICA MARKET SNAPSHOT
FIGURE 39 UAE MARKET SNAPSHOT
FIGURE 40 SAUDI ARABIA MARKET SNAPSHOT
FIGURE 41 SOUTH AFRICA MARKET SNAPSHOT
FIGURE 42 REST OF MIDDLE EAST AND AFRICA MARKET SNAPSHOT
FIGURE 43 KEY STRATEGIC DEVELOPMENTS
FIGURE 44 STERICYCLE: COMPANY INSIGHT
FIGURE 45 STERICYCLE: SWOT ANALYSIS
FIGURE 46 DANIELS HEALTH: COMPANY INSIGHT
FIGURE 47 DANIELS HEALTH: SWOT ANALYSIS
FIGURE 48 WASTE MANAGEMENT INC.: COMPANY INSIGHT
FIGURE 49 WASTE MANAGEMENT INC.: SWOT ANALYSIS
FIGURE 50 CARDINAL HEALTH, INC.: COMPANY INSIGHT
FIGURE 51 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
FIGURE 52 COVANTA HOLDING CORPORATION: COMPANY INSIGHT
FIGURE 53 US ECOLOGY, INC.: COMPANY INSIGHT
FIGURE 54 BIOMEDICAL WASTE SOLUTION LLC: COMPANY INSIGHT
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY INSIGHT
FIGURE 56 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
FIGURE 57 STRYKER: COMPANY INSIGHT
FIGURE 58 MEDICAL WASTE SERVICE: COMPANY INSIGHT

Product Code: 40255

Pharmaceutical Waste Management Market Valuation - 2026-2032

The increasing volume of pharmaceutical waste generated globally owing mostly to population growth and improved healthcare facilities is a major concern. People are becoming more aware of the environmental and health risks associated with inappropriate pharmaceutical waste disposal. There is an increasing emphasis on proper pharmaceutical waste management to reduce these dangers while also ensuring environmental sustainability by enabling the market to surpass a revenue of USD 1662.35 Billion valued in 2024 and reach a valuation of around USD 2631.59 Billion by 2032.

Furthermore, severe rules and guidelines enforced by governments and environmental organizations governing pharmaceutical waste disposal are driving up the demand for effective pharmaceutical waste management solutions. To reduce the negative consequences of pharmaceutical waste, regulatory organizations are increasingly focusing on ensuring its safe and environmentally appropriate disposal. In addition, the pharmaceutical waste management market is being driven by the increasing adoption of advanced technologies such as high-temperature incineration, landfilling, and non-incineration methods such as chemical treatments and autoclaves. These methods facilitate the safe disposal and destruction of pharmaceutical waste lowering the environmental and health concerns associated with inappropriate disposal. The growing need for pharmaceutical waste management by enabling the market to grow at a CAGR of 5.91% from 2026 to 2032.

Pharmaceutical Waste Management Market: Definition/ Overview

Pharmaceutical waste management is the safe and efficient disposal of various types of pharmaceutical waste created during the lifecycle of pharmaceutical products. This waste consists of expired or unused medications, contaminated packaging, and other items used in the production, distribution, and administration of pharmaceuticals. The goal of pharmaceutical waste management is to reduce the environmental and health concerns associated with inappropriate disposal as well as potential harm to human health.

Pharmaceutical waste management is used in a variety of settings including pharmaceutical production plants, hospitals, clinics, pharmacies, and research organizations. These organizations generate a substantial amount of pharmaceutical waste which includes expired or unused pharmaceuticals, contaminated packaging, and laboratory chemicals. Proper waste management is critical to meeting environmental requirements, reducing pollution, and protecting public health.

How Does the Increasing Volume of Healthcare Waste Drive the Pharmaceutical Waste Management Market?

The global pharmaceutical business is rapidly expanding, resulting in increased waste output. According to the IQVIA Institute for Human Data Science, global pharmaceutical spending is expected to reach USD 1.8 Trillion by 2026, increasing at a 3-6% compound annual growth rate. According to the World Health Organization (WHO), global pharmaceutical production has expanded from 300 billion Standard Units in 1985 to more than 3 trillion Standard Units in 2020, a 10-fold increase. This expansion directly adds to the increasing volume of pharmaceutical waste that requires effective disposal.

Governments around the world are enacting harsher laws for pharmaceutical waste disposal in response to growing environmental concerns. According to the Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. According to the European Medicines Agency (EMA), environmental risk evaluations are now needed for 88% of new drug applications in the European Union, up from 10% in 2005, resulting in increased demand for proper waste management solutions.

Furthermore, the growing public awareness of the environmental and health dangers connected with inappropriate medication disposal is propelling market growth. A study published in Environmental Toxicology and Chemistry discovered that 88% of the 93 most often prescribed medications can be found in trace levels in surface, ground, and drinking water. According to the US Geological Survey, 80% of US streams contain trace levels of human pharmaceuticals. This awareness is prompting additional programs for proper disposal, such as the United States Drug Enforcement Administration's National Prescription Drug Take Back Day, which gathered 744,082 pounds of unneeded prescription medicines in October 2021 alone.

How Does the High Capital Investment Hamper the Pharmaceutical Waste Management Market?

The large capital expenditure necessary for successful pharmaceutical waste management presents a substantial barrier for hospitals, healthcare institutes, and pharmaceutical corporations. These organizations must devote significant financial resources to creating sophisticated waste management systems that comply with environmental requirements and reduce pollution. The high expense of these systems which involve advanced technologies for collecting, processing, and disposing of both hazardous and non-hazardous pharmaceutical waste put a burden on these institutions' budgets.

The high capital requirements for pharmaceutical waste management stifle market expansion by acting as a barrier to entry for smaller healthcare facilities and pharmaceutical corporations. Smaller businesses are unable to afford the large upfront expenses associated with deploying modern waste management technology and instead choose cheaper, less effective options or incorrect disposal techniques. This increases environmental contamination and endangers public health contradicting the goals of pharmaceutical waste management.

Category-Wise Acumens

How Do Increased Procedures Related to Chronic Diseases Drive the Hazardous Pharmaceutical Waste?

The hazardous segment is estimated to dominate the pharmaceutical waste management market. Chronic diseases such as cancer, diabetes, cardiovascular disease, and respiratory disorders frequently necessitate extensive and long-term medical interventions such as surgeries, chemotherapy, radiation therapy, and medication. These treatments produce a large amount of hazardous medical waste which includes contaminated sharps, chemotherapeutic medications, pathological waste, and infectious materials.

As the global frequency of chronic diseases increases due to reasons such as aging populations, sedentary lifestyles, and unhealthy dietary habits, so does the volume of hazardous medical waste generated. The increasing number of healthcare operations associated with chronic diseases is likely to have a major impact on the hazardous waste segment of the medical waste management market. Healthcare facilities such as hospitals, clinics, and specialized treatment centers must consequently establish appropriate waste management systems to properly and efficiently manage the rising volume of hazardous medical waste.

Furthermore, proper treatment of hazardous medical waste created during chronic disease operations is critical to maintaining public health and environmental safety. The regulatory rules for waste management are being edited and tightened to address the issues provided by the growing volume of hazardous medical waste. As a result, healthcare facilities are rapidly investing in innovative waste management technology and solutions to comply with these laws while reducing the environmental and health concerns connected with hazardous medical waste.

How do the Increasing Awareness and New Technologies Drive the Hospitals in the Market?

Hospitals accounted for the largest market share due to rising awareness campaigns and the introduction of new technologies. The healthcare industry is becoming more conscious of the necessity of effective medical waste management for maintaining public health and environmental safety. As a result, there has been an increase in awareness campaigns, conferences, and training sessions centered on new technology and best practices for medical waste management.

Furthermore, the introduction of new medical waste management technologies is critical to boosting the growth of the hospital and diagnostic laboratory markets. Healthcare facilities are progressively using advanced technologies to manage medical waste safely and efficiently, such as autoclaving, microwave treatment, steam sterilization, and chemical disinfection. These technologies have various benefits such as improved waste sterilization, less environmental impact, and cheaper operational costs. As a result, hospitals, diagnostic laboratories, and other healthcare facilities are expanding their investments in modern technologies to improve waste management.

Furthermore, the increasing emphasis on regulatory compliance and environmental sustainability is encouraging healthcare organizations to invest in innovative medical waste management technologies. Regulatory bodies are enforcing stricter norms and regulations for medical waste management and treatment to reduce environmental pollution and public health threats. As a result, rising awareness and the introduction of new technologies are likely to propel the end-user segment particularly hospitals and diagnostic laboratories into the medical waste management market.

Country/Region-wise Acumens

How will the Increasing Adoption of Pharmaceutical Waste Management Services Drive the Market in North America?

North America is estimated to dominate the pharmaceutical waste management market during the forecast period. North America, particularly the United States, has one of the most severe regulatory regimes for managing pharmaceutical waste. According to the US Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. The Resource Conservation and Recovery Act (RCRA) and the Hazardous Waste Pharmaceuticals Rule, which were enacted in 2019, established tight standards for pharmaceutical waste treatment, resulting in market growth in this region.

Furthermore, North Americans are becoming more conscious of the proper disposal of unused or expired drugs. The Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day has witnessed a considerable turnout. The DEA stated in 2021 that their Take Back Day programs had gathered a total of 15,989,566 pounds (more than 7,995 tons) of prescription medicines since the program's commencement in 2010. This increased awareness and engagement in such programs is generating demand for pharmaceutical waste management services in the region.

Will the Growing Prevalence of Chronic Diseases Boost the Market in the European Region?

Europe region is estimated to exhibit substantial growth within the market during the forecast period. Europe has enacted stringent laws for pharmaceutical waste treatment, resulting in market growth. The European Commission's 2020 pharmaceutical plan intends to minimize the environmental effect of medicines by 30% by 2030. According to the European Medicines Agency (EMA), 88% of new medicine applications in the European Union now include an environmental risk assessment, up from 10% in 2005. This regulatory climate compels pharmaceutical businesses and healthcare facilities to invest in effective waste management solutions.

Furthermore, Europe has a high incidence of pharmaceutical use, which can be attributed in part to its aging population. According to Eurostat data, the proportion of people aged 65 and over is expected to rise from 20.3% in 2019 to 29.4% by 2050. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European pharmaceutical market is estimated to be worth €213.4 billion in 2020. This high consumption rate, along with an aging population that normally requires more prescriptions, creates a substantial amount of pharmaceutical waste that must be properly managed.

Competitive Landscape

The pharmaceutical waste management market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations focus on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the pharmaceutical waste management market include:

Cardinal Health

Covanta Holding Corporation

US Ecology, Inc.

Stericycle

BioMedical Waste Solution LLC

Dickinson and Company

Waste Management, Inc.

Daniels Health

Sharps Compliance, Inc.

Stryker

Becton

Latest Developments

In February 2021, Cardinal Health WaveMark(TM) Supply Management & Workflow Solutions partnered with HIMSS Analytics(R), a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM), to help healthcare systems optimize and benchmark their progress in clinical and operational supply chains.

In February 2023, EcoSteris announced the development of a cutting-edge medical waste plant in Summerville, creating a unique and creative footprint in the business.

In May 2021, UPS Healthcare and Stericycle formed an ongoing relationship to manage medical waste reverse logistics, including trash classification and disposal. UPS and Stericycle hope to provide comprehensive logistical support to the healthcare industry as a result of their collaboration.

1 INTRODUCTION

1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP-DOWN APPROACH
2.1 RESEARCH FLOW
2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

3.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OVERVIEW
3.2 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT ABSOLUTE MARKET OPPORTUNITY
3.3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET ATTRACTIVENESS, BY REGION
3.4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
3.6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
3.7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
3.8 FUTURE MARKET OPPORTUNITIES
3.9 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

4.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
4.2 MARKET DRIVERS
- 4.2.1 INCREASING GOVERNMENT INITIATIVES FOR PROPER DISPOSAL OF MEDICATIONS
- 4.2.2 INCREASING NUMBERS OF THE BOOMER GENERATION
4.3 RESTRAINTS
- 4.3.1 LACK OF AWARENESS ABOUT THE IMPACTS OF IMPROPER DISPOSAL OF MEDICATIONS
- 4.3.2 HIGH COSTS ASSOCIATED WITH THIS WASTE MANAGEMENT
4.4 OPPORTUNITIES
- 4.4.1 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES ACROSS THE GLOBE TO SUPPORT
4.5 IMPACT OF COVID19 ON GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET
4.6 MACROECONOMIC ANALYSIS
4.7 PORTER'S FIVE FORCES ANALYSIS
- 4.7.1 THREAT OF NEW ENTRANTS
- 4.7.2 THREAT OF SUBSTITUTES
- 4.7.3 BARGAINING POWER OF SUPPLIERS
- 4.7.4 BARGAINING POWER OF BUYERS
- 4.7.5 INTENSITY OF COMPETITIVE RIVALRY
4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY NATURE OF WASTE

5.1 OVERVIEW
5.2 HAZARDOUS PHARMACEUTICAL WASTE
5.3 NON-HAZARDOUS PHARMACEUTICAL WASTE

6 MARKET, BY TYPE OF WASTE

6.1 OVERVIEW
6.2 OVER THE COUNTER WASTE
6.3 NON-CONTROLLED PRESCRIPTION DRUGS
6.4 CONTROLLED DRUGS
6.5 HAZARDOUS DRUGS

7 MARKET, BY END USER

7.1 OVERVIEW
7.2 HOSPITALS
7.3 PHARMACIES
7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
7.5 CLINICS & PHYSICIANS' OFFICE
7.6 OTHERS

8 MARKET, BY GEOGRAPHY

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 NORTH AMERICA MARKET SNAPSHOT
- 8.2.2 U.S.
- 8.2.3 CANADA
- 8.2.4 MEXICO
8.3 EUROPE
- 8.3.1 EUROPE MARKET SNAPSHOT
- 8.3.2 GERMANY
- 8.3.3 U.K.
- 8.3.4 FRANCE
- 8.3.5 ITALY
- 8.3.6 SPAIN
- 8.3.7 REST OF EUROPE
8.4 ASIA PACIFIC
- 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
- 8.4.2 CHINA
- 8.4.3 INDIA
- 8.4.4 JAPAN
- 8.4.5 REST OF ASIA PACIFIC
8.5 LATIN AMERICA
- 8.5.1 LATIN AMERICA MARKET SNAPSHOT
- 8.5.2 BRAZIL
- 8.5.3 ARGENTINA
- 8.5.4 REST OF LATIN AMERICA
8.6 MIDDLE EAST AND AFRICA
- 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
- 8.6.2 UAE
- 8.6.3 SAUDI ARABIA
- 8.6.4 SOUTH AFRICA
- 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 COMPANY MARKET RANKING ANALYSIS
9.3 COMPANY REGIONAL FOOTPRINT
9.4 COMPANY INDUSTRY FOOTPRINT

10 COMPANY PROFILES

10.1 STERICYCLE
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 COMPANY INSIGHTS
- 10.1.3 PRODUCT BENCHMARKING
- 10.1.4 WINNING IMPERATIVES
- 10.1.5 CURRENT FOCUS & STRATEGIES
- 10.1.6 THREAT FROM COMPETITION
- 10.1.7 SWOT ANALYSIS
10.2 DANIELS HEALTH
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 COMPANY INSIGHTS
- 10.2.3 PRODUCT BENCHMARKING
- 10.2.4 WINNING IMPERATIVES
- 10.2.5 CURRENT FOCUS & STRATEGIES
- 10.2.6 THREAT FROM COMPETITION
- 10.2.7 SWOT ANALYSIS
10.3 WASTE MANAGEMENT INC.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 COMPANY INSIGHTS
- 10.3.3 PRODUCT BENCHMARKING
- 10.3.4 WINNING IMPERATIVES
- 10.3.5 CURRENT FOCUS & STRATEGIES
- 10.3.6 THREAT FROM COMPETITION
- 10.3.7 SWOT ANALYSIS
10.4 CARDINAL HEALTH, INC.
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 COMPANY INSIGHTS
- 10.4.3 SEGMENT BREAKDOWN
- 10.4.4 PRODUCT BENCHMARKING
10.5 COVANTA HOLDING CORPORATION
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 COMPANY INSIGHTS
- 10.5.3 PRODUCT BENCHMARKING
10.6 US ECOLOGY, INC.
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 COMPANY INSIGHTS
- 10.6.3 PRODUCT BENCHMARKING
10.7 BIOMEDICAL WASTE SOLUTION LLC
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 COMPANY INSIGHTS
- 10.7.3 PRODUCT BENCHMARKING
10.8 BECTON, DICKINSON AND COMPANY
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 COMPANY INSIGHTS
- 10.8.3 SEGMENT BREAKDOWN
- 10.8.4 PRODUCT BENCHMARKING
10.9 STRYKER
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 COMPANY INSIGHTS
- 10.9.3 PRODUCT BENCHMARKING
10.10 MEDICAL WASTE SERVICE
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 COMPANY INSIGHTS
- 10.10.3 PRODUCT BENCHMARKING